摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-amino-5-(trifluoromethyl)phenyl)piperidine-1-carboxylic acid tert-butyl ester | 1261551-53-4

中文名称
——
中文别名
——
英文名称
4-(2-amino-5-(trifluoromethyl)phenyl)piperidine-1-carboxylic acid tert-butyl ester
英文别名
tert-butyl 4-(2-amino-5-trifluoromethyl-phenyl)-piperidine-1-carboxylate;4-(2-Amino-5-trifluoromethyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester;tert-butyl 4-[2-amino-5-(trifluoromethyl)phenyl]piperidine-1-carboxylate
4-(2-amino-5-(trifluoromethyl)phenyl)piperidine-1-carboxylic acid tert-butyl ester化学式
CAS
1261551-53-4
化学式
C17H23F3N2O2
mdl
——
分子量
344.377
InChiKey
IOCXSKSJSDCXKF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    389.4±42.0 °C(Predicted)
  • 密度:
    1.209±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    55.6
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE AND PHARMACEUTICALS CONTAINING THE SAME
    申请人:CHUGAI SEIYAKU KABUSHIKI KAISHA
    公开号:US20160002251A1
    公开(公告)日:2016-01-07
    The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.
    本发明提供了一种二氢吡啶嗪-3,5-二酮衍生物或其盐,或化合物或盐的溶剂化合物,一种药物,一种药物组合物,一种钠依赖性磷酸盐转运体抑制剂,以及作为活性成分的化合物的高磷血症、继发性甲状旁腺功能亢进症、慢性肾功能衰竭、慢性肾病和与血管钙化相关的动脉硬化的预防和/或治疗剂,以及预防和/或治疗的方法。
  • INSECTICIDAL COMPOUNDS
    申请人:Cassayre Jerome Yves
    公开号:US20120115884A1
    公开(公告)日:2012-05-10
    A compound of formula (I) wherein A, p, R 1 , R 3 , R 4 , R 5 , and R 8 are as defined in claim 1 . Furthermore, the present invention relates to intermediates used to prepare compounds of formula (I), to methods of using them to combat and control insect, acarine, nematode and mollusc pests and to insecticidal, acaricidal, nematicidal and molluscicidal compositions comprising them.
    化合物的化学式(I),其中A、p、R1、R3、R4、R5和R8的定义如权利要求书所述。此外,本发明涉及用于制备化合物(I)的中间体,用于对抗和控制昆虫、螨、线虫和软体动物害虫的方法,以及包含它们的杀虫剂、杀螨剂、杀线虫剂和杀软体动物剂组合物。
  • Insecticidal compounds
    申请人:Cassayre Jerome Yves
    公开号:US08586593B2
    公开(公告)日:2013-11-19
    A compound of formula (I) wherein A, p, R1, R3, R4, R5, and R8 are as defined in claim 1. Furthermore, the present invention relates to intermediates used to prepare compounds of formula (I), to methods of using them to combat and control insect, acarine, nematode and mollusc pests and to insecticidal, acaricidal, nematicidal and molluscicidal compositions comprising them.
    式(I)的化合物,其中A、p、R1、R3、R4、R5和R8的定义如权利要求1所述。此外,本发明涉及用于制备式(I)化合物的中间体,用于对抗和控制昆虫、螨、线虫和软体动物害虫的方法,以及包含它们的杀虫、杀螨、杀线虫和杀软体动物组合物。
  • DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE
    申请人:Chugai Seiyaku Kabushiki Kaisha
    公开号:EP2975030A1
    公开(公告)日:2016-01-20
    The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure, comprising the compound as an active ingredient, and a method for prevention and/or treatment.
    本发明提供了一种二氢哒嗪-3,5-二酮衍生物或其盐,或该化合物或该盐的溶液剂、一种药物、一种药物组合物、一种钠依赖性磷酸盐转运体抑制剂,以及一种预防和/或治疗高磷血症、继发性甲状旁腺功能亢进症和慢性肾功能衰竭的药物,其中包含该化合物作为活性成分,以及一种预防和/或治疗方法。
  • PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION.
    申请人:Chugai Seiyaku Kabushiki Kaisha
    公开号:EP3928779A1
    公开(公告)日:2021-12-29
    The present invention provides a pharmaceutical composition containing, as an active ingredient, a dihydropyridazine-3,5-dione derivative or a salt thereof or a solvate of these, wherein the composition is administered in combination with a phosphorus adsorbent.
    本发明提供了一种药物组合物,其活性成分为二氢哒嗪-3,5-二酮衍生物或其盐或其溶液,其中该组合物与磷吸附剂结合使用。
查看更多